Your browser doesn't support javascript.
loading
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Palmieri, Carlo; Stein, Rob C; Liu, Xinxue; Hudson, Emma; Nicholas, Hanna; Sasano, Hironobu; Guestini, Fouzia; Holcombe, Chris; Barrett, Sophie; Kenny, Laura; Reed, Sadie; Lim, Adrian; Hayward, Larry; Howell, Sacha; Charles Coombes, R.
Afiliação
  • Palmieri C; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. c.palmieri@liverpool.ac.uk.
  • Stein RC; Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. c.palmieri@liverpool.ac.uk.
  • Liu X; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK. c.palmieri@liverpool.ac.uk.
  • Hudson E; NIHR University College London Hospitals Biomedical Research Centre, London, NW1 2PG, UK.
  • Nicholas H; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
  • Sasano H; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
  • Guestini F; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
  • Holcombe C; Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.
  • Barrett S; Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.
  • Kenny L; Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, L7 8XP, UK.
  • Reed S; Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, UK.
  • Lim A; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
  • Hayward L; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
  • Howell S; Department of Radiology, Imperial College NHS Foundation Trust, London, W8 6RF, UK.
  • Charles Coombes R; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, EH4 2XU, UK.
Breast Cancer Res Treat ; 167(1): 407, 2018 01.
Article em En | MEDLINE | ID: mdl-29071491
ABSTRACT
In the original publication of the article, a part of acknowledgement section was missed out. The omitted acknowledgement is given below 'The study was coordinated by the Imperial Clinical Trials Unit-Cancer, Imperial College London and Sponsored by Imperial College London. The Imperial Clinical Trials Unit receives funding from the National Institute for Health (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This study was supported by Imperial Experimental Cancer Medicine Centre and Cancer Research UK Imperial Centre'.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido